These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37113740)

  • 1. Differences in non-positive intention to accept the COVID-19 booster vaccine between three countries in the cross-border region Meuse-Rhine Euroregion: The Netherlands, Belgium, and Germany.
    van Bilsen CJA; Stabourlos C; Moonen CPB; Brinkhues S; Demarest S; Hanssen DAT; van Loo IHM; Savelkoul PHM; Philippsen D; van der Zanden BAM; Dukers-Muijrers NHTM; Hoebe CJPA
    Vaccine X; 2023 Aug; 14():100306. PubMed ID: 37113740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 pandemic response in the Meuse-Rhine Euroregion: methods, participation and recommendations of a longitudinal cross-border study.
    Stabourlos C; van Bilsen CJA; Brinkhues S; Moonen CPB; Demarest S; Hanssen DAT; van Loo IHM; Savelkoul PHM; Philippsen D; van der Zanden BAM; Dukers-Muijrers NHTM; Hoebe CJPA
    Arch Public Health; 2023 May; 81(1):91. PubMed ID: 37179369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-border mobility in the Meuse-Rhine Euroregion: impact of COVID-19 border restrictions on everyday activities and visiting social network members.
    van Bilsen CJA; Brinkhues S; Hoebe CJPA; Stabourlos C; Moonen CPB; Demarest S; Hanssen DAT; van Loo IHM; Savelkoul PHM; Philippsen D; van der Zanden BAM; Dukers-Muijrers NHTM
    Front Public Health; 2024; 12():1281072. PubMed ID: 38726234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impacts and Lessons Learned of the First Three COVID-19 Waves on Cross-Border Collaboration in the Field of Emergency Medical Services and Interhospital Transports in the Euregio-Meuse-Rhine: A Qualitative Review of Expert Opinions.
    Sommer A; Rehbock C; Vos C; Borgs C; Chevalier S; Doreleijers S; Gontariuk M; Hennau S; Pilot E; Schröder H; Van der Auwermeulen L; Ghuysen A; Beckers SK; Krafft T
    Front Public Health; 2022; 10():841013. PubMed ID: 35372226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of uncertainty and unwillingness to receive the COVID-19 booster vaccine: An observational study of 22,139 fully vaccinated adults in the UK.
    Paul E; Fancourt D
    Lancet Reg Health Eur; 2022 Mar; 14():100317. PubMed ID: 35132400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do Side Effects to the Primary COVID-19 Vaccine Reduce Intentions for a COVID-19 Vaccine Booster?
    Geers AL; Clemens KS; Colagiuri B; Jason E; Colloca L; Webster R; Vase L; Seig M; Faasse K
    Ann Behav Med; 2022 Aug; 56(8):761-768. PubMed ID: 35640203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine hesitancy for the COVID-19 vaccine booster dose among nursing home staff fully vaccinated with the primary vaccination course in Belgium.
    Digregorio M; Van Ngoc P; Delogne S; Meyers E; Deschepper E; Dardenne N; Duysburgh E; De Rop L; De Burghgraeve T; Coen A; De Clercq N; De Sutter A; Verbakel JY; Cools P; Heytens S; Buret L; Scholtes B
    Vaccine X; 2024 Jan; 16():100453. PubMed ID: 38361529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy of a Brief, Altruism-Eliciting Video Intervention in Enhancing COVID-19 Vaccination Intentions Among a Population-Based Sample of Younger Adults: Randomized Controlled Trial.
    Zhu P; Tatar O; Griffin-Mathieu G; Perez S; Haward B; Zimet G; Tunis M; Dubé È; Rosberger Z
    JMIR Public Health Surveill; 2022 May; 8(5):e37328. PubMed ID: 35544437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model: A Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region.
    Ghazy RM; Abdou MS; Awaidy S; Sallam M; Elbarazi I; Youssef N; Fiidow OA; Mehdad S; Hussein MF; Adam MF; Abdullah FSA; Rebai WK; Raad EB; Hussein M; Shehata SF; Ismail II; Salam AA; Samhouri D
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Dynamic Relationship between the Intention and Final Decision for the COVID-19 Booster: A Study among Students and Staff at the University of Liège, Belgium.
    Paridans M; Monseur J; Donneau AF; Gillain N; Husson E; Leclercq D; Meuris C; Darcis G; Moutschen M; Saegerman C; Gillet L; Bureau F; Guillaume M; Pétré B
    Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sociocognitive predictors of the intention of healthcare workers to receive the influenza vaccine in Belgian, Dutch and German hospital settings.
    Lehmann BA; Ruiter RA; van Dam D; Wicker S; Kok G
    J Hosp Infect; 2015 Mar; 89(3):202-9. PubMed ID: 25586987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptance of the COVID-19 vaccine booster dose and associated factors among the elderly in China based on the health belief model (HBM): A national cross-sectional study.
    Qin C; Yan W; Du M; Liu Q; Tao L; Liu M; Liu J
    Front Public Health; 2022; 10():986916. PubMed ID: 36589991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, Usability, and Acceptability of a Chatbot for Promoting COVID-19 Vaccination in Unvaccinated or Booster-Hesitant Young Adults: Pre-Post Pilot Study.
    Luk TT; Lui JHT; Wang MP
    J Med Internet Res; 2022 Oct; 24(10):e39063. PubMed ID: 36179132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different Interventions for COVID-19 Primary and Booster Vaccination? Effects of Psychological Factors and Health Policies on Vaccine Uptake.
    Sprengholz P; Henkel L; Böhm R; Betsch C
    Med Decis Making; 2023 Feb; 43(2):239-251. PubMed ID: 36404766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral Intention to Get a Booster Dose of COVID-19 Vaccine among Chinese Factory Workers.
    Zhang K; Fang Y; Chan PS; Cao H; Chen H; Hu T; Chen Y; Zhou X; Wang Z
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Influencing COVID-19 Vaccination Intentions Among College Students: A Cross-Sectional Study in India.
    Jain L; Vij J; Satapathy P; Chakrapani V; Patro B; Kar SS; Singh R; Pala S; Sankhe L; Modi B; Bali S; Rustagi N; Rajagopal V; Kiran T; Goel K; Aggarwal AK; Gupta M; Padhi BK
    Front Public Health; 2021; 9():735902. PubMed ID: 34976911
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictors of the Third (Booster) Dose of COVID-19 Vaccine Intention among the Healthcare Workers in Saudi Arabia: An Online Cross-Sectional Survey.
    Alobaidi S; Hashim A
    Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caregivers' intentions to COVID-19 vaccination for their children in China: a cross-sectional survey.
    Feng H; Zhu H; Zhang H; Cao L; Li L; Wang J; Huang Y; Lai X; Lyu Y; Jing R; Guo J; Yin Z; Fang H
    Hum Vaccin Immunother; 2021 Dec; 17(12):4799-4805. PubMed ID: 34756123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.